
|Videos|November 8, 2021
Dr. Miner emphasizes individualized testosterone therapy dosing
Author(s)Urology Times staff
Advertisement
In this video, Martin M. Miner, MD, discusses the takeaways of the study, “Subcutaneous Testosterone Enanthate and the Effect of Body Mass Index on Serum Testosterone in Men with Testosterone Deficiency,” presented recently at the 2021 Sexual Medicine Society of North America Fall Scientific Meeting. Miner is the founder of the Men’s Health Center at Miriam Hospital and clinical professor of family medicine and urology in the Warren Alpert School of Medicine at Brown University, Providence, Rhode Island.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Matthew Galsky, MD, on how EV/pembrolizumab is redefining the MIBC treatment paradigm
2
Cretostimogene Grenadenorepvec: Mechanism and Rationale
3
Published BOND-003 data show durable responses with cretostimogene in NMIBC
4
Pearls & Perspectives: From Prostate Cancer Diagnosis to Patient Advocacy, with Gabe Canales
5












